Hepatocellular dysfunction occurs earlier than the onset of hyperdynamic circulation during sepsis

Shock

Volumn 3, Issue 1, 1995, Pages 21-26

  Wang, Ping ^a   Ba, Zheng F ^a   Chaudry, Irshad H ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; DIAGNOSTIC AGENT; INDOCYANINE GREEN; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; CELL HYPOXIA; FEMALE; HEART OUTPUT; HEMODYNAMICS; IMMUNOLOGY; INTESTINE PERFORATION; LIVER; LIVER DISEASE; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; RAT STRAIN; SEPSIS; SMALL INTESTINE; TIME; VASCULARIZATION;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMAL; BLOOD PRESSURE; CARDIAC OUTPUT; CELL HYPOXIA; DINOPROSTONE; FEMALE; HEMODYNAMICS; INDOCYANINE GREEN; INTESTINAL PERFORATION; INTESTINE, SMALL; LIVER; LIVER DISEASES; MICROCIRCULATION; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TUMOR NECROSIS FACTOR;

EID: 0029180674     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/00024382-199501000-00003     Document Type: Article

References (36)

1. Baue AE: Multiple Organ Failure. In Baue AE (ed): Multiple Organ Failure: Patient Care and Prevention. St. Louis MO: Mosby Year Book, 1990, pp 421-470.
2. Deitch EA: Multiple Organ Failure: Pathophysiology and potential future therapy. Ann Surg 216:117-134, 1992.
3. Cerra FB: Multiple organ failure syndrome. In Bihari DJ, Cerra FB (eds): Multiple Organ Failure. Fullerton, CA: Society of Critical Care Med., 1989, pp 1-24.
4. Marshall J, Sweeney D: Microbial infection and the septic response in critical surgical illness. Arch Surg 125:17-23, 1990.
5. Parker MM: Cardiac dysfunction in human septic shock. Ann Intern Med 113:227-242, 1990.
6. Lang CH, Bagby GJ, Ferguson JL, Spitzer JJ: Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am J Physiol 246:R331-R337, 1984.
7. Wang P, Zhou M, Rana MW, Ba ZF, Chaudry IH: Differential alterations in microvascular perfusion in various organs during early and late sepsis. Am J Physiol 263:G38-G43, 1992.
8. Wang P, Ba ZF, Chaudry IH: Hepatic extraction of indocyanine green is depressed early in sepsis despite increased hepatic blood flow and cardiac output. Arch Surg 126:219-224, 1991.
9. Wang P, Ba ZF, Chaudry IH: Increase in hepatic blood flow during early sepsis is due to increased portal blood flow. Am J Physiol 261:R1507-R1512, 1991.
10. Wang P, Ba ZF, Ayala A, Chaudry IH: Hepatocellular dysfunction persists during early sepsis despite increased volume of crystalloid resuscitation. J Trauma 32:389-397, 1992.
11. Seccombe JF, Schaff HV: Vasoactive Factors Produced by the Endothelium: Physiology and Surgical Implications. Austin TX: R. G. Landes Co., 1994, pp 1-137.
12. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock-A review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
13. Wang P, Hauptman JG, Chaudry IH: Hepatocellular dysfunction occurs early after hemorrhage and persists despite fluid resuscitation. J Surg Res 48:464-470, 1990.
14. Hauptman JG, DeJong GK, Blasko KA, Chaudry IH: Measurement of hepatocellular function, cardiac output, effective blood volume and oxygen saturation in the rat. Am J Physiol 257:R439-R444, 1989.
15. Hauptman JG, Wang P, DeJong GK, Chaudry IH: Improved methodology for the evaluation of the velocity of clearance of indocyanine green in the rat. Circ Shock 32:26-32, 1991.
16. Wang P, Chaudry IH: Crystalloid resuscitation restores but does not maintain cardiac output following severe hemorrhage. J Surg Res 50:163-169, 1991.
17. Shepherd AP, Riedel GL: Continuous measurement of intestinal mucosal blood flow by laser-Doppler velocimetry. Am J Physiol 242:G668-G672, 1982.
18. Shepherd AP, Riedel GL, Kiel JW, Haumschild DJ, Maxwell LC: Evaluation of an infrared laser-Doppler blood flowmeter. Am J Physiol 252: G832-G839, 1987.
19. Ertel W, Morrison MH, Ayala A, Perrin MM, Chaudry IH: Blockade of prostaglandin production increases cachectin synthesis and prevents depression of macrophage functions following hemorrhagic shock. Ann Surg 213:265-271, 1991.
20. Tokunaga O, Yamada T, Fan J, Watanabe T: Age-related decline in prostacyclin synthesis by human aortic endothelial cells: Qualitative and quantitative analysis. Am J Pathol 138:941-949, 1991.
21. Dahn MS, Wilson RF, Lange P, Stone A, Jacobs LA: Hepatic parenchymal oxygen tension following injury and sepsis. Arch Surg 125:441-443, 1990.
22. Dahn MS, Lange MP, Wilson RF, Jacobs LA, Mitchell RA: Hepatic blood flow and splanchnic oxygen consumption measurements in clinical sepsis. Surgery 107:295-301, 1990.
23. Townsend MC, Hampton WW, Haybron DM, Schirmer WJ, Fry DE: Effective organ blood flow and bioenergy status in murine peritonitis. Surgery 100:205-213, 1986.
24. Machiedo GW, Hurd T, Rush BR, Dikdan G, McGee J, Lysz T: Temporal relationship of hepatocellular dysfunction and ischemia in sepsis. Arch Surg 123:424-427, 1988.
25. Wang P, Ayala A, Ba ZF, Zhou M, Perrin MM, Chaudry IH: Tumor necrosis factor-a produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation. Am J Physiol 265:G126-G132, 1993.
26. Ayala A, Kisala JM, Felt JA, Perrin MM, Chaudry IH: Does endotoxin tolerance prevent the release of inflammatory monokines (IL-1, IL-6, or TNF) during sepsis? Arch Surg 127:191-197, 1992.
27. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophage to release inflammatory mediators (IL-1, IL-6 and TNF). Circ Shock 36:191-199, 1992.
28. Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chaudry IH: The complex pattern of cytokines in sepsis-Association between prostaglan-dins, cachectin and interleukins. Ann Surg 214:141-148, 1991.
29. Busund R, Lindsetmo R-O, Rasmussen L-T, Rokke O, Rekvig OP, Revhaug A: Tumor necrosis factor and interleukin 1 appearance in experimental Gram-negative septic shock. The effects of plasma exchange with albumin and plasma infusion. Arch Surg 126:591-597, 1991.
30. Marano MA, Fong Y, Moldawer LL, Wei H, Calvano SE, Tracey KJ, Barie PS, Manogue K, Cerami A, Shires GT, Lowry SF: Serum cachectin/ tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 170:32-38, 1990.
31. Marks JD, Marks CB, Luce JM, Montgomery B, Turner J, Metz CA, Murray JF: Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis 141:94-97, 1990.
32. Dahn MS, Hsu CJ, Lange MP, Jefferson LS: Effects of tumor necrosis factor-a on glucose and albumin production in primary cultures of rat hepatocytes. Metabolism 43:476-480, 1994.
33. Walsh CJ, Sugerman HJ, Mullen PG, Carey PD, Leeper-Woodford SK, Jesmok GJ, Ellis EF, Fowler AA: Monoclonal antibody to tumor necrosis factor a attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis. Arch Surg 127:138-145, 1992.
34. Chalkiadakis GE, Kostakis A, Karayannacos PE, Chalkiadakis ME, Sgouromali S, Giamarellou H, Skalkeas GD: Pentoxifylline in the treatment of experimental peritonitis in rats. Arch Surg 120:1141-1144, 1985.
35. Schlag G, Redl H, Davies J, Haller I: Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock 2:10-18, 1994.
36. 2+-related hepatocellular alterations during intra-abdominal sepsis. Am J Physiol 263:R553-R558, 1992.